SCHEMBL23095093

SCHEMBL23095093

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5ccc(-c6cccnc6)cc5)cc4)cc(-c4cccc5c4ccc4ccccc45)n3)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.49
CYP19A1 P11511 3/20 0.48
CYP11B2 P19099 3/20 0.48
CYP17A1 P05093 1/20 0.48
DHODH Q02127 1/20 0.47
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TNF P01375 1/20 0.41
CYP2C9 P11712 3/20 0.41
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP1A1 P04798 1/20 0.40
PRKDC P78527 1/20 0.40
CYP1B1 Q16678 1/20 0.40
PGR P06401 1/20 0.39
KMO O15229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23095092 0.95 CYP11B1 (0.56) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL23095090 0.94 KDM4E (0.50) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL19650543 0.90 CYP11B1 (0.58) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL24252594 0.89 CYP11B1 (0.55) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL30857479 0.89 CYP11B1 (0.55) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL23095091 0.89 KDM4E (0.50) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL23095071 0.89 ALDH1A1 (0.52) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL23095081 0.89 CYP11B1 (0.56) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL17917896 0.88 KDM4E (0.47) CYP11B1CYP19A1CYP11B2CYP17A1DHODH
SCHEMBL19650651 0.88 KDM4E (0.49) CYP11B1CYP19A1CYP11B2CYP17A1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10950797-B2 Organic electroluminescent device HODOGAYA CHEMICAL CO., LTD. (JP) 2021-03-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10950797-B2 Organic electroluminescent device SLC29A2, SLC29A1, NUDT1 CYP11B1 1493/4885CYP19A1 1301/4885CYP11B2 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.